1-866-647-3279

14

Nov 2022

FDA Concludes that Nicotinamide Mononucleotide (NMN) Cannot be Marketed or Sold in Dietary Supplements
FDA Concludes that Nicotinamide Mononucleotide (NMN) Cannot be Marketed or Sold in Dietary Supplements
By
The FDA recently published responses to several new dietary ingredient notifications (NDIN) submitted for nicotinamide mononucleotide (most notably the November 8, 2022 response to Inner Mongolia Kingdomway Pharmaceutical Ltd. “Kingdomway”). […] Read More >>

25

Oct 2022

GRAS, New Dietary Ingredients (NDI’s), Old Dietary Ingredients (ODI’s), and Food Additives – Is Your Product Classified Correctly?
GRAS, New Dietary Ingredients (NDI’s), Old Dietary Ingredients (ODI’s), and Food Additives – Is Your Product Classified Correctly?
By
To be used in foods and dietary supplements, ingredients must: be determined to be Generally Recognized as Safe (GRAS), be approved as a New Dietary Ingredient (NDI), be considered an […] Read More >>
FDA Authorized list of Old Dietary Ingredients Under Development
September 26, 2017 By
  Service(s) related to this article:  Dietary Supplement Consulting, Food Compliance Consulting, New Dietary Ingredients FDA has scheduled a public meeting on October 3, 2017 to discuss developing a list […] Read More >>
FDA’s New Dietary Ingredient Notification: How Manufacturing Process Changes an ODI into a NDI
September 22, 2016 By
The Dietary Supplement Health and Education Act (DSHEA) formed a strong framework for the regulation of New Dietary Ingredient (NDI) notifications as a pre-market safety review process. NDI is defined […] Read More >>
CFSAN Constituent Update – Draft Guidance on Premarket Safety Notifications for Dietary Supplements
August 12, 2016 By
This is an article taken from the official FDA U.S. Food and Drug Administration website. The following is a press announcement from FDA of interest to our Constituent Update subscribers. […] Read More >>
FDA Nanomaterial guidance released to support the responsible development of nanotechnology in Food, Dietary Supplements, and Cosmetics
September 22, 2014 By
Three final guidance documents and one draft guidance were recently released on FDA nanomaterials regarding the development of nanotechnology in food, dietary supplements, and cosmetic products and reflects FDA’s current […] Read More >>
There & Back Again With Dr. Daniel Fabricant
June 13, 2014 By
After three years as the director of FDA’s division of dietary supplements, Dr. Daniel Fabricant, has rejoined the Natural Products Association (NPA) as its CEO. In his first presentation to […] Read More >>
dicentra’s Regulatory Webinar – Q1: March 26, 2013
March 26, 2013 By
March 26, 2013: dicentra conducted its first webinar of 2013. Critical American and Canadian updates including FDA’s proposed rules to amend cGMPs for food facilities under FSMA, the FDA’s Draft […] Read More >>
FDA New Dietary Ingredient Notifications
October 2, 2012 By
FDA considers dietary supplements that contain new dietary ingredients and that have not submitted new dietary ingredient Notifications to be adulterated. Any supplement that is considered to be adulterated can […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions

      *Please note: dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in Canada, to the exclusion of all other countries.